Macrophage-activating lipopeptide-2 and corticotropin-releasing hormone stimulate the inflammatory signalling in human sebocytes through activation of stearoyl-CoA desaturase and fatty acid desaturase 2

被引:8
|
作者
Zouboulis, C. C. [1 ]
Angres, S. [1 ,2 ,3 ,4 ,5 ]
机构
[1] Brandenburg Med Sch Theodor Fontane, Dessau Med Ctr, Dept Dermatol, Dessau, Germany
[2] Brandenburg Med Sch Theodor Fontane, Dessau Med Ctr, Dept Venereol, Dessau, Germany
[3] Brandenburg Med Sch Theodor Fontane, Dessau Med Ctr, Dept Allergol, Dessau, Germany
[4] Brandenburg Med Sch Theodor Fontane, Dessau Med Ctr, Dept Immunol, Dessau, Germany
[5] Fac Hlth Sci Brandenburg, Dessau, Germany
关键词
PROPIONIBACTERIUM-ACNES; ARACHIDONIC-ACID; EXPRESSION; RECEPTOR; DIFFERENTIATION; TRANSCRIPTION; LIPOGENESIS; PROMOTES; COENZYME; GLANDS;
D O I
10.1111/jdv.17016
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background The macrophage-activating lipopeptide-2 (MALP-2) activates cells carrying a functional Toll-like receptor (TLR)-2/6. Human sebocytes express functional TLR-2, TLR-4 and CD14. Upregulation of stearoyl-CoA desaturase (SCD) and fatty acid desaturase-2 (FADS2) expression induces pro-inflammatory sebaceous activity. On the other hand, corticotropin-releasing hormone (CRH) is likely to serve as an autocrine stress hormone in human sebocytes. In addition to its antiproliferative, lipogenetic and androgen-activating functions, CRH exhibits a pro-inflammatory action and its expression is upregulated in acne-involved sebaceous glands. Objective Determination of the pro-inflammatory function of MALP-2 and CRH and clarification of the option that MALP-2 and/or CRH activity on human sebocytes might be mediated through SCD and/or FADS2. Methods SZ95 sebocytes were treated with MALP-2, CRH and the SCD inhibitor/ligand FPCA. SCD, FADS2, TLR-2 mRNA and protein levels and IL-6 and IL-8 secretion were investigated. Intracellular CRH levels were assessed under treatment with CRH, MALP-2, linoleic acid and arachidonic acid. Phorbol 12-myristate 13-acetate and dexamethasone served as positive and negative controls, respectively. Results MALP-2 upregulated SCD, FADS2, TLR-2 mRNA and protein levels and IL-6 and IL-8 secretion from SZ95 sebocytes. Co-incubation of SZ95 sebocytes with MALP-2/FPCA did not affect the MALP-2-induced SCD mRNA upregulation but reduced FADS2 mRNA levels and inhibited IL-8 secretion. CRH induced an early, low-level SCD and FADS2 upregulation and TLR-2 and IL-8 secretion. High intracellular CRH concentrations could be detected early after CRH treatment and persisted up to 24 h. MALP-2 stimulated intracellular CRH levels. Conclusions MALP-2 stimulates the inflammatory signalling in human sebocytes through SCD and FADS2 activation. Inhibition of FADS2 mRNA levels and IL-8 secretion through MALP-2/FCPA co-incubation and diminution of fatty acid unsaturation might lead to a reduction of pro-inflammatory sebaceous lipids. CRH upregulates inflammatory signalling via the SCD/FADS2 pathway, and MALP-2 selectively enhances CRH levels in human sebocytes.
引用
收藏
页码:493 / 501
页数:9
相关论文
共 1 条